Evidence map›Paper›PMID 33493092›Full record

ArticleAmerican journal of respiratory cell and molecular biology2021

Notch3 Deficiency Attenuates Pulmonary Fibrosis and Impedes Lung-Function Decline.

Laura Vera, Paula Garcia-Olloqui, Eva Petri, Ana Cristina Viñado, Pablo S Valera, Zuriñe Blasco-Iturri, Isabel A Calvo, Itziar Cenzano, Clemens Ruppert, Javier J Zulueta and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Combatting pulmonary fibrosis withChinese herbal medicines · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Notch signaling regulates pulmonary fibrosis.Frontiers in cell and developmental biology · 2024
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Laura VeraDepartment of Regenerative Medicine and.
Paula Garcia-OlloquiDepartment of Regenerative Medicine and.
Eva PetriDepartment of Regenerative Medicine and.
Ana Cristina ViñadoDepartment of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain.
Pablo S ValeraDepartment of Regenerative Medicine and.
Zuriñe Blasco-IturriMolecular and Functional Biomarkers Lab, Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), San Sebastián, Spain.
Isabel A CalvoDepartment of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain.
Itziar CenzanoDepartment of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain.
Clemens RuppertBiobank of the Universities of Giessen and Marburg Lung Center and the European Idiopathic Pulmonary Fibrosis Registry, German Center for Lung Research, Giessen, Germany; and.
Javier J ZuluetaPulmonary Department, Clinica Universidad de Navarra, Pamplona, Spain.
Felipe ProsperDepartment of Regenerative Medicine and.
Borja SaezDepartment of Hematology-Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain.ORCID 0000-0001-7908-7089
Ana Pardo-SagantaDepartment of Regenerative Medicine and.ORCID 0000-0002-5926-6255
Universidad de Navarra · ESCIC biomaGUNE · ESClinica Universidad de Navarra · ESGerman Center for Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast activation includes differentiation to myofibroblasts and is a key feature of organ fibrosis. The Notch pathway has been involved in myofibroblast differentiation in several tissues, including the lung. Here, we identify a subset of collagen-expressing cells in the lung that exhibit Notch3 activity at homeostasis. After injury, this activation increases, being found in αSMA-expressing myofibroblasts in the mouse and human fibrotic lung. Although previous studies suggest a contribution of Notch3 in stromal activation,

Indexed as

ActinsAnimalsBleomycinCell DifferentiationCells, CulturedCell SurvivalCollagenDisease Models, AnimalDisease ProgressionHumansLungMaleMiceMice, Inbred C57BLMice, KnockoutMyofibroblastsActinsalpha-smooth muscle actin, mouseBleomycinCollagenNOTCH3 protein, humanNotch3 protein, mouseReceptor, Notch3fibroblast activationlung functionmyofibroblast differentiationNotch3 signalingpulmonary fibrosis

Identifiers

PMID33493092
OpenAlexW3125498742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.